Study identification

PURI

https://redirect.ema.europa.eu/resource/1000000052

EU PAS number

EUPAS1000000052

Study ID

1000000052

Official title and acronym

Association between exposure to GLP-1 receptor agonists and risk of suicide-related and self-harm-related events

DARWIN EU® study

No

Study countries

United Kingdom

Study description

Cohort study aimed at investigating the association between GLP-1 receptor agonists and increased risk of suicide-related and self-injury-related events.

Study status

Finalised
Research institution and networks

Institutions

Contact details

Andrei Barbulescu

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
EMA
Study protocol
Updated protocol
English (1011.55 KB - PDF)View document
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable